R&F Capital Advisors’s Usana Health Sciences USNA Stock Holding History

R&F Capital Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,753	Closed	-$230K	–	831
2016 Q4	$230K	Buy	+3,753	New	+$245K	0.08%	380

Other funds holding USNA

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

R&F Capital Advisors's USNA Position: Q1 2017 in Review

R&F Capital Advisors sold out of Usana Health Sciences (USNA) in Q1 2017, closing a stake of 3,753 shares — an estimated $230K sold.

R&F Capital Advisors first reported a position in USNA in Q4 2016 and held it in 1 quarter. The position peaked at $230K in Q4 2016. 155 funds tracked by Wall St. Rank hold USNA as of Q1 2017.

R&F Capital Advisors reported no remaining Usana Health Sciences position as of Q1 2017 after selling out during the quarter.
R&F Capital Advisors sold 3,753 Usana Health Sciences shares in Q1 2017, an estimated $230K.
R&F Capital Advisors first reported a position in Usana Health Sciences in Q4 2016 and held it in 1 quarter.
R&F Capital Advisors's Usana Health Sciences position peaked at $230K in Q4 2016.
155 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.